• News and Events
  • Testimonials
  • Contact us
Hungarotrial
  • About us
    • Company profile
    • Protocol Challenge
    • Company history
    • Mission statement
    • Management team
    • Company brochure
    • Quality policy
    • Data Protection Policy
  • Services
    • General Overview
    • Phase I-IV services
    • Medical device services
    • CRA outsourcing
    • Support for COVID-19 research
  • Therapeutic experience
    • Focus Therapeutic Areas
    • Investigator database
  • Why HungaroTrial?
    • HungaroTrial’s advantage
    • Benefits of doing Clinical Trials in CEE
    • Free whitepaper request
  • About us
    • Company profile
    • Protocol Challenge
    • Company history
    • Mission statement
    • Management team
    • Company brochure
    • Quality policy
    • Data Protection Policy
  • Services
    • General Overview
    • Phase I-IV services
    • Medical device services
    • CRA outsourcing
    • Support for COVID-19 research
  • Therapeutic experience
    • Focus Therapeutic Areas
    • Investigator database
  • Why HungaroTrial?
    • HungaroTrial’s advantage
    • Benefits of doing Clinical Trials in CEE
    • Free whitepaper request
  • News and Events
    • Webinars
    • Conference participation
    • News releases
    • Sign up for Newsletter
  • Testimonials
  • Contact us
    • Locations
    • Request for information
    • Careers
  • Webinars
  • Conference participation
  • News releases
  • Sign up for Newsletter
Hungarotrial » News and Events » Webinars
Webinars

The most challenging points of the transition period from MDD to MDR – and their solution

Time: 20 May 2021
The European Union’s new Medical Devices Regulation (MDR), which replaces a decades-old legislation, will require manufacturers to make significant changes in product development, data reporting and their quality management system.
Details and registration
Copyright: HungaroTrial 2021